Patients were adults with chronic HCV genotype @b infection who were treatment-naive ; previous non-responders to peginterferon alfa plus ribavirin ; or medically ineligible for , previously intolerant of , or ineligible for and intolerant of peginterferon alfa plus ribavirin .